Cognitive Computing in Pharmacovigilance: Revamping Drug Safety Using an Advanced Computing System

The cost of conducting pharmacovigilance is increasing year-on-year with the growing volume of cases received by the pharmaceutical companies. Among the major functions of a pharmacovigilance department, case management is considered to be the most resource-intensive process. Cognitive computing algorithms could automate several activities in pharmacovigilance, decreasing the overall costs of conducting pharmacovigilance. This white paper explores the use of …

Re-Imagining Drug Safety Powered by Genomics, Information Integration and Emerging Technologies

|| Whitepaper by Tata Consultancy Services. Pub. 17/08/2017 Abstract Scientific advancements, emerging technologies, and extensive information have created new opportunities for modernizing drug safety.  Simultaneously, the pharmacovigilance regulatory landscape is shifting to ensure improved safety for patients. This is the time to reimagine the  drug safety sector to transform it into an advanced, proactive and patient-centric practice. Introduction The global …

Trials supported by electronic health records

Trials supported by electronic health records – a game-changer for study design and execution Professor Martin Gibson will be revealing the secrets of the successful delivery of GlaxoSmithKline’s (GSK) real world Salford Lung Study at BioData World Congress 2016 on 26 October in Cambridge. Widely recognised as the first study of its kind globally, the Salford Lung Study is a …

Adis whitepaper

Whitepaper: The changing faces of device safety

The benefits of literature monitoring throughout the lifecycle Executive Summary One would be forgiven for thinking that the current changes to the guidelines for medical device safety meant just an increase in workload for the manufacturers. But look beyond the “overalls” and you will see that these changes present a golden opportunity for the device industry to demonstrate the real-world benefits it has on …

Adis

Adis launches services to support pharmacovigilance departments

Adis Pharmacovigilance will help pharmacovigilance teams to face the challenges of regulatory literature monitoring. Under the name of Adis Pharmacovigilance, Adis, a leading global provider of drug information, has launched an expanded range of services to support pharmacovigilance departments. This new suite of services includes monitoring special situation Individual Case Safety Reports (ICSRs), local literature and customised source coverage, ongoing …

Drug Safety Europe 2016

Ensuring Compliance for Cloud: A Risk Management Guide for Life Sciences Organizations

In an effort to manage cost pressures, optimize operational efficiencies, and build robust IT capabilities, the life sciences industry is also shifting to the cloud. However, being a highly regulated industry, players face significant compliance challenges while leveraging the cloud. In addition to managing security risks in a shared computing environment, organizations also need to ensure that regulatory commitments are …

Digital Reimagination of Clinical Trials

Digital technologies help transform and reposition businesses around the globe. The life sciences industry has also felt their impact, and numerous attempts have been made over the last few years to pilot the use of these technologies in clinical trials. Given the common challenges of on-time patient recruitment, retention, adherence, and stringent clinical trial  execution timelines faced by life sciences …

Q2 2016 Cloud

Q2 Pharmacovigilance and Drug Safety Conferences – What did you miss?

Q2 Pharmacovigilance and Drug Safety Conferences – What did you miss? Great industry conferences are often the result of a combination of factors: good planning, strong speakers, with real depth in expertise and a passion for their topic, and attendees/delegates with great questions.  When all three line up in one event, all participants gain tremendous value from the presentations and …

Anti-Microbial Resistance Congress 2016

It’s a Global Crisis: What the Review on Antimicrobial Resistance Wants to Do About AMR

   It’s a Global Crisis: What the Review on Anti-Microbial Resistance Wants to Do About AMR  After collaborating on a series of papers surrounding the growing health concern of drug-resistant infections, the Review on Antimicrobial Resistance released a final report this month, which outlined the steps and interventions this team of experts deems necessary for international progress. The facts and …